These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14962152)

  • 21. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
    Mulnard RA; Cotman CW; Kawas C; van Dyck CH; Sano M; Doody R; Koss E; Pfeiffer E; Jin S; Gamst A; Grundman M; Thomas R; Thal LJ
    JAMA; 2000 Feb; 283(8):1007-15. PubMed ID: 10697060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study.
    Ariza J; Gudiol F; Pallares R; Viladrich PF; Rufi G; Corredoira J; Miravitlles MR
    Ann Intern Med; 1992 Jul; 117(1):25-30. PubMed ID: 1596044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin E for Alzheimer's disease and mild cognitive impairment.
    Isaac MG; Quinn R; Tabet N
    Cochrane Database Syst Rev; 2008 Jul; (3):CD002854. PubMed ID: 18646084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.
    Wilcock GK; Lilienfeld S; Gaens E
    BMJ; 2000 Dec; 321(7274):1445-9. PubMed ID: 11110737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.
    Morris JC; Cyrus PA; Orazem J; Mas J; Bieber F; Ruzicka BB; Gulanski B
    Neurology; 1998 May; 50(5):1222-30. PubMed ID: 9595967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, placebo-controlled, multicenter study of Cerebrolysin for Alzheimer's disease.
    Bae CY; Cho CY; Cho K; Hoon Oh B; Choi KG; Lee HS; Jung SP; Kim DH; Lee S; Choi GD; Cho H; Lee H
    J Am Geriatr Soc; 2000 Dec; 48(12):1566-71. PubMed ID: 11129744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diseases from Chlamydia psittaci and Chlamydia pneumoniae].
    Med Monatsschr Pharm; 2001 Aug; 24(8):259-61. PubMed ID: 11515199
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
    Anderson JL; Muhlestein JB; Carlquist J; Allen A; Trehan S; Nielson C; Hall S; Brady J; Egger M; Horne B; Lim T
    Circulation; 1999 Mar; 99(12):1540-7. PubMed ID: 10096928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.
    Feldman HH; Doody RS; Kivipelto M; Sparks DL; Waters DD; Jones RW; Schwam E; Schindler R; Hey-Hadavi J; DeMicco DA; Breazna A;
    Neurology; 2010 Mar; 74(12):956-64. PubMed ID: 20200346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.
    Sparks DL; Sabbagh MN; Connor DJ; Lopez J; Launer LJ; Browne P; Wasser D; Johnson-Traver S; Lochhead J; Ziolwolski C
    Arch Neurol; 2005 May; 62(5):753-7. PubMed ID: 15883262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential.
    Abushakra S; Porsteinsson A; Scheltens P; Sadowsky C; Vellas B; Cummings J; Gauthier S; Hey JA; Power A; Wang P; Shen L; Tolar M
    J Prev Alzheimers Dis; 2017; 4(3):149-156. PubMed ID: 29182706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of Long-term Doxycycline Treatment and Cognitive-Behavioral Therapy on Fatigue Severity in Patients with Q Fever Fatigue Syndrome (Qure Study): A Randomized Controlled Trial.
    Keijmel SP; Delsing CE; Bleijenberg G; van der Meer JWM; Donders RT; Leclercq M; Kampschreur LM; van den Berg M; Sprong T; Nabuurs-Franssen MH; Knoop H; Bleeker-Rovers CP
    Clin Infect Dis; 2017 Apr; 64(8):998-1005. PubMed ID: 28329131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
    Doody RS; Thomas RG; Farlow M; Iwatsubo T; Vellas B; Joffe S; Kieburtz K; Raman R; Sun X; Aisen PS; Siemers E; Liu-Seifert H; Mohs R; ;
    N Engl J Med; 2014 Jan; 370(4):311-21. PubMed ID: 24450890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised, blinded, placebo controlled trial of doxycycline for chronic seronegative arthritis.
    Smieja M; MacPherson DW; Kean W; Schmuck ML; Goldsmith CH; Buchanan W; Hart LE; Mahony JB
    Ann Rheum Dis; 2001 Dec; 60(12):1088-94. PubMed ID: 11709448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Chlamydia pneumoniae infection in adult asthma: a before-after trial.
    Hahn DL
    J Fam Pract; 1995 Oct; 41(4):345-51. PubMed ID: 7561707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization.
    Simor AE; Phillips E; McGeer A; Konvalinka A; Loeb M; Devlin HR; Kiss A
    Clin Infect Dis; 2007 Jan; 44(2):178-85. PubMed ID: 17173213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study.
    Stamm WE; Hicks CB; Martin DH; Leone P; Hook EW; Cooper RH; Cohen MS; Batteiger BE; Workowski K; McCormack WM
    JAMA; 1995 Aug; 274(7):545-9. PubMed ID: 7629982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.
    Rösler M; Anand R; Cicin-Sain A; Gauthier S; Agid Y; Dal-Bianco P; Stähelin HB; Hartman R; Gharabawi M
    BMJ; 1999 Mar; 318(7184):633-8. PubMed ID: 10066203
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.